LIANBIO's ticker is and the CUSIP is 53000N108. A total of 45 filers reported holding LIANBIO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $916,630 | -59.6% | 615,188 | -38.3% | 0.00% | – |
Q2 2023 | $2,271,662 | +13.3% | 996,343 | -2.6% | 0.00% | – |
Q1 2023 | $2,005,289 | +19.5% | 1,023,107 | 0.0% | 0.00% | – |
Q4 2022 | $1,677,895 | -18.0% | 1,023,107 | 0.0% | 0.00% | – |
Q3 2022 | $2,046,000 | -8.2% | 1,023,107 | -0.9% | 0.00% | – |
Q2 2022 | $2,229,000 | -34.2% | 1,032,083 | +87.7% | 0.00% | – |
Q4 2021 | $3,388,000 | – | 550,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,282,084 | $4,472,885 | 6.12% |
Perceptive Advisors | 57,558,451 | $112,814,563 | 3.33% |
SCHF (GPE), LLC | 937,500 | $1,838 | 3.24% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,303,573 | $6,475,003 | 0.65% |
Cormorant Asset Management, LP | 4,250,000 | $8,330 | 0.55% |
Affinity Asset Advisors, LLC | 650,000 | $1,267,500 | 0.42% |
22NW, LP | 141,223 | $276,797 | 0.17% |
MYDA Advisors LLC | 120,000 | $235,200 | 0.09% |
Logos Global Management LP | 280,000 | $548,800 | 0.08% |
TANG CAPITAL MANAGEMENT LLC | 209,600 | $410,816 | 0.06% |